Midterm recruitment report

Summary
Midterm recruitment report. This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays. The Global Health EDCTP3 Joint Undertaking reserves the right to terminate the MOBILE MEN project if milestone MS16 has not been achieved and by month 18 no clinical trial participant has received long-acting cabotegravir.